197 related articles for article (PubMed ID: 38424164)
1. Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels.
Djamgoz MBA
Br J Cancer; 2024 May; 130(9):1415-1419. PubMed ID: 38424164
[TBL] [Abstract][Full Text] [Related]
2. Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease.
Djamgoz MB; Onkal R
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):66-84. PubMed ID: 23116083
[TBL] [Abstract][Full Text] [Related]
3. Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.
Bugan I; Kucuk S; Karagoz Z; Fraser SP; Kaya H; Dodson A; Foster CS; Altun S; Djamgoz MBA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):569-579. PubMed ID: 30894674
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antiarrhythmic effect of combining inhibition of Ca²⁺-activated K⁺ (SK) channels and voltage-gated Na⁺ channels in an isolated heart model of atrial fibrillation.
Kirchhoff JE; Diness JG; Sheykhzade M; Grunnet M; Jespersen T
Heart Rhythm; 2015 Feb; 12(2):409-18. PubMed ID: 25496982
[TBL] [Abstract][Full Text] [Related]
5. Effect of Voltage-Gated Sodium Channel Inhibitors on the Metastatic Behavior of Prostate Cancer Cells: A Meta-Analysis.
Yildirim-Kahriman S
Pak J Biol Sci; 2023 Jul; 26(8):419-426. PubMed ID: 37937335
[TBL] [Abstract][Full Text] [Related]
6. Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: Effects of combination with ranolazine.
Lee A; Fraser SP; Djamgoz MBA
J Cell Physiol; 2019 Dec; 234(12):23066-23081. PubMed ID: 31222761
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Na
Fraser SP; Onkal R; Theys M; Bosmans F; Djamgoz MBA
Br J Pharmacol; 2022 Feb; 179(3):473-486. PubMed ID: 34411279
[TBL] [Abstract][Full Text] [Related]
8. Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: control by voltage-gated sodium channel activity.
Rizaner N; Onkal R; Fraser SP; Pristerá A; Okuse K; Djamgoz MB
Eur Biophys J; 2016 Oct; 45(7):735-748. PubMed ID: 27665102
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid phenethyl ester: Inhibition of metastatic cell behaviours via voltage-gated sodium channel in human breast cancer in vitro.
Fraser SP; Hemsley F; Djamgoz MBA
Int J Biochem Cell Biol; 2016 Feb; 71():111-118. PubMed ID: 26724521
[TBL] [Abstract][Full Text] [Related]
10. Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine.
Qiu S; Fraser SP; Pires W; Djamgoz MBA
Clin Exp Metastasis; 2022 Aug; 39(4):679-689. PubMed ID: 35643818
[TBL] [Abstract][Full Text] [Related]
11. Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons.
Peters CH; Sokolov S; Rajamani S; Ruben PC
Br J Pharmacol; 2013 Jun; 169(3):704-16. PubMed ID: 23472826
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of Nav channels and α1-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine.
Virsolvy A; Farah C; Pertuit N; Kong L; Lacampagne A; Reboul C; Aimond F; Richard S
Sci Rep; 2015 Dec; 5():17969. PubMed ID: 26655634
[TBL] [Abstract][Full Text] [Related]
13. Discovery and evaluation of nNa
Dutta S; Lopez Charcas O; Tanner S; Gradek F; Driffort V; Roger S; Selander K; Velu SE; Brouillette W
Bioorg Med Chem; 2018 May; 26(9):2428-2436. PubMed ID: 29673714
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na(+) current than on the persistent Na(+) current in central neurons.
Terragni B; Scalmani P; Colombo E; Franceschetti S; Mantegazza M
Neuropharmacology; 2016 Nov; 110(Pt A):223-236. PubMed ID: 27450092
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the effects of class Ib antiarrhythmics on cardiac NaV1.5-encoded channels by accessory NaVβ subunits.
Zhu W; Wang W; Angsutararux P; Mellor RL; Isom LL; Nerbonne JM; Silva JR
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156986
[TBL] [Abstract][Full Text] [Related]
16. Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study.
Fairhurst C; Watt I; Martin F; Bland M; Brackenbury WJ
Sci Rep; 2015 Nov; 5():16758. PubMed ID: 26577038
[TBL] [Abstract][Full Text] [Related]
17. Riluzole: Anti-invasive effects on rat prostate cancer cells under normoxic and hypoxic conditions.
Rizaner N; Uzun S; Fraser SP; Djamgoz MBA; Altun S
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):254-264. PubMed ID: 32304618
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic Effects of Late Sodium Current Inhibitors in a Swine Model of Heart Failure.
Goldstein RE; Klein MG; Ouimet SP; Shou M; Hood MN; Flagg TP; Haigney MC
J Card Fail; 2019 Oct; 25(10):828-836. PubMed ID: 31461671
[TBL] [Abstract][Full Text] [Related]
19. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.
Gumushan Aktas H; Akgun T
Biomed Pharmacother; 2018 Oct; 106():770-775. PubMed ID: 29990870
[TBL] [Abstract][Full Text] [Related]
20. [Lidocaine in oncological surgery: the role of blocking in voltage-gated sodium channels. A narrative review].
Soto G; Calero F; Naranjo M
Braz J Anesthesiol; 2020; 70(5):527-533. PubMed ID: 32951865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
